Aptalis Pharma

Pharmaceutical Manufacturing • Bridgewater, New Jersey, United States • 11-20 Employees

Company overview

Headquarters	100 SOMERSET CORPORATE, BRIDGEWATER, New Jersey 08807, US
Website	aptalispharmatech.com
NAICS	3254
Founded	2011
Employees	11-20

Key Contacts at Aptalis Pharma

Gianfranco Carboni

Finance Director

Jorge Martinez

Director, Marketing

Aptalis Pharma Email Formats

Aptalis Pharma uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@adarepharma.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@adarepharma.com	100%

About Aptalis Pharma

Aptalis Pharmaceutical Technologies offers a broad portfolio of oral drug delivery technology platforms: Customized Drug Release, Bioavailability Enhancement, and Taste Masking for ODT's (orally disintegrating tablets) and other dosage forms. Together, these technology platforms combined with best in class R&D, formulation development and manufacturing capabilities enable Aptalis Pharmaceutical Technologies to produce customized drug formulation solutions for partners across a range of dosage forms and therapies with high patient acceptability. Aptalis Pharmaceutical Technologies develops and manufactures products, both for itself and for partners, as well as support the drug development process for the Aptalis Pharma pipeline and portfolio of products. Aptalis Pharma Inc. is a privately held, leading specialty pharmaceutical company providing innovative, effective therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. Aptalis has manufacturing and commercial operations in the United States, the European Union and Canada, and its products include ZENPEP®, CANASA®, CARAFATE®, PYLERA®, RECTIV®, VIOKACE™, ULTRESA™, LACTEOL®, DELURSAN®, PANZYTRAT®, and SALOFALK®. Aptalis also formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary technology platforms including bioavailability enhancement of poorly soluble drugs, custom release profiles, and taste-masking/orally disintegrating tablet (ODT) formulations. For more information, visit www.aptalispharma.com.

Aptalis Pharma revenue & valuation

Annual revenue	$1,454,435
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$4,700,000
Total funding	No funding

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Manager

Director

Employees by Department

Aptalis Pharma has 16 employees across 7 departments.

Departments

Number of employees

Funding Data

Aptalis Pharma has never raised funding before.

Frequently asked questions

Aptalis Pharma is located in Bridgewater, New Jersey, US.

Aptalis Pharma was founded in 2011, making it 15 years old. The company has established itself as a significant player in its industry over this time.

Aptalis Pharma has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Aptalis Pharma

Gianfranco Carboni

Finance Director

Jorge Martinez

Director, Marketing

4.8

40,000 users